Literature DB >> 18640396

Energy balance in congenital generalized lipodystrophy type I.

Sasha Taleban1, Heather T Carew, Helén L Dichek, Samir S Deeb, David Hollenback, David S Weigle, David E Cummings, John D Brunzell.   

Abstract

Congenital generalized lipodystrophy type 1 (CGL-1) is characterized by an absence of adipose tissue and decreased serum leptin levels. Low leptin levels in CGL-1 support the claim that subjects are hypermetabolic and hyperphagic. The present study examines this claim. We determined 24-hour energy expenditure (24-h EE) (kilocalories) (n = 2) and resting metabolic rate (RMR) per kilogram of lean body mass (LBM) (n = 3) in CGL-1 and in 18 healthy control subjects. The 24-h EEs of control and subjects with CGL were compared with respect to kilocalories required per day relative to kilograms of LBM and with respect to RMR relative to kilograms of LBM. Fasting leptin, adiponectin, and 24-hour ghrelin levels were also measured in subjects with CGL-1. The 24-h EE per kilogram of LBM for the subjects with CGL-1 falls on the same regression line observed for this relationship in the controls. The RMR per kilogram of LBM in subjects with CGL-1 also was similar to that in controls. Both 24-h EE and RMR were quite increased when reported per kilogram of total body weight. Subjects with CGL-1 also have decreased fasting leptin and adiponectin hormone levels and no premeal ghrelin rise. People with CGL-1 have similar RMR and daily caloric requirements as healthy controls when these parameters are expressed as a function of LBM. Appetite-regulating hormone levels in CGL-1 suggest that multiple factors act to control appetite in these individuals.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18640396      PMCID: PMC3259008          DOI: 10.1016/j.metabol.2008.04.008

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  36 in total

Review 1.  Lipoatrophy revisited.

Authors:  M L Reitman; E Arioglu; O Gavrilova; S I Taylor
Journal:  Trends Endocrinol Metab       Date:  2000-12       Impact factor: 12.015

2.  Lipodystrophy and gigantism with associated endocrine manifestations. A new diencephalic syndrome?

Authors:  M SEIP
Journal:  Acta Paediatr       Date:  1959-11       Impact factor: 2.299

3.  Generalized lipoatrophy, hepatic cirrhosis, disturbed carbohydrate metabolism and accelerated growth (lipoatrophic diabetes). Longitudinal observations and metabolic studies.

Authors:  R SCHWARTZ; I A SCHAFER; A E RENOLD
Journal:  Am J Med       Date:  1960-06       Impact factor: 4.965

4.  An undiagnosed endocrinometabolic syndrome: report of 2 cases.

Authors:  W BERARDINELLI
Journal:  J Clin Endocrinol Metab       Date:  1954-02       Impact factor: 5.958

5.  Energy expenditure and adaptive responses to an acute hypercaloric fat load in humans with lipodystrophy.

Authors:  David B Savage; Peter R Murgatroyd; V Krishna Chatterjee; Stephen O'Rahilly
Journal:  J Clin Endocrinol Metab       Date:  2004-12-21       Impact factor: 5.958

6.  Congenital leptin deficiency is associated with severe early-onset obesity in humans.

Authors:  C T Montague; I S Farooqi; J P Whitehead; M A Soos; H Rau; N J Wareham; C P Sewter; J E Digby; S N Mohammed; J A Hurst; C H Cheetham; A R Earley; A H Barnett; J B Prins; S O'Rahilly
Journal:  Nature       Date:  1997-06-26       Impact factor: 49.962

Review 7.  Ghrelin and energy balance: focus on current controversies.

Authors:  David E Cummings; Karen E Foster-Schubert; Joost Overduin
Journal:  Curr Drug Targets       Date:  2005-03       Impact factor: 3.465

Review 8.  Generalized lipodystrophy, congenital and acquired (lipoatrophy).

Authors:  M Seip; O Trygstad
Journal:  Acta Paediatr Suppl       Date:  1996-06

9.  A gene for congenital generalized lipodystrophy maps to human chromosome 9q34.

Authors:  A Garg; R Wilson; R Barnes; E Arioglu; Z Zaidi; F Gurakan; N Kocak; S O'Rahilly; S I Taylor; S B Patel; A M Bowcock
Journal:  J Clin Endocrinol Metab       Date:  1999-09       Impact factor: 5.958

10.  Enzymatic activity of naturally occurring 1-acylglycerol-3-phosphate-O-acyltransferase 2 mutants associated with congenital generalized lipodystrophy.

Authors:  Wasim Haque; Abhimanyu Garg; Anil K Agarwal
Journal:  Biochem Biophys Res Commun       Date:  2005-02-11       Impact factor: 3.575

View more
  4 in total

1.  Physiological responses to leptin levels in lipodystrophy: a model for other hypoleptinemias?

Authors:  Michael Rosenbaum; Rudolph L Leibel
Journal:  J Clin Invest       Date:  2018-07-16       Impact factor: 14.808

2.  A Single Complex Agpat2 Allele in a Patient With Partial Lipodystrophy.

Authors:  Marjoleine F Broekema; Maarten P G Massink; Joep De Ligt; Edwin C A Stigter; Houshang Monajemi; Jeroen De Ridder; Boudewijn M T Burgering; Gijs W van Haaften; Eric Kalkhoven
Journal:  Front Physiol       Date:  2018-09-26       Impact factor: 4.566

3.  Altered acylated ghrelin response to food intake in congenital generalized lipodystrophy.

Authors:  Camilla O D Araújo; Renan M Montenegro; Amanda P Pedroso; Virgínia O Fernandes; Ana Paula D R Montenegro; Annelise B de Carvalho; Lila M Oyama; Carla S C Maia; Eliane B Ribeiro
Journal:  PLoS One       Date:  2021-01-07       Impact factor: 3.240

4.  Congenital Generalized Lipoatrophy (Berardinelli-Seip Syndrome) Type 1: Description of Novel AGPAT2 Homozygous Variants Showing the Highly Heterogeneous Presentation of the Disease.

Authors:  Giovanni Ceccarini; Silvia Magno; Caterina Pelosini; Federica Ferrari; Maria Rita Sessa; Gaia Scabia; Margherita Maffei; Isabelle Jéru; Olivier Lascols; Corinne Vigouroux; Ferruccio Santini
Journal:  Front Endocrinol (Lausanne)       Date:  2020-02-14       Impact factor: 5.555

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.